Korean J Hepatobiliary Pancreat Surg.  2012 Aug;16(3):89-92. 10.14701/kjhbps.2012.16.3.89.

Surgical treatment for advanced pancreatic cancer

  • 1Department of Surgery, Kyungpook National University Medical Center, Daegu, Korea. ksg@knu.ac.kr


The role of multimodality therapy and surgery for the treatment of locally advanced pancreatic cancer remains to be determined. Although no randomized trials have been done to determine the optimal management of this difficult clinical problem, numerous series reporting successful surgical resection with negative (R0) or microscopic margin (R1) showing favorable long-term survival provide a basis for an aggressive approach in selected cases of advanced cancer of the pancreas. In the absence of conclusive clinical trials, neoadjuvant treatment followed by surgical resection seems to be the optimal approach for locally advanced pancreatic cancers when the potential for surgical resection is suggested by preoperative high quality CT imaging. In particular, when the tumor is within the criteria for borderline resectable pancreatic cancer, efforts to achieve R0 resection are warranted. For those selected cases invading the hepatic artery and superior mesenteric artery, combined arterial resection and reconstruction may be performed to achieve R0 resection. Nonetheless, such a complex procedure should be balanced by a high rate of postoperative complications. In contrast, in cases of tumors invading the celiac axis, R0 resection by combined celiac axis resection can be performed without a high rate of postoperative complications. Survival benefit needs to be verified by further studies in the future.


Carcinoma; Pancreatic ductal; Resection; Borderline resectable

MeSH Terms

Axis, Cervical Vertebra
Hepatic Artery
Mesenteric Artery, Superior
Neoadjuvant Therapy
Pancreatic Neoplasms
Postoperative Complications


1. Cancer Institute. Surveillance, Epidemiology, and End Results (SEER). http://seer.cancer.gov/faststats/.
2. Fortner JG, Kim DK, Cubilla A, et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977. 186:42–50.
3. Bold RJ, Charnsangavej C, Cleary KR, et al. Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg. 1999. 3:233–243.
4. Sasson AR, Hoffman JP, Ross EA, et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg. 2002. 6:147–157.
5. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004. 8:935–949.
6. Nakano H, Bachellier P, Weber JC, et al. Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies. Hepatogastroenterology. 2002. 49:258–262.
7. Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009. 16:1736–1744.
8. Karmazanovsky G, Fedorov V, Kubyshkin V, et al. Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging. 2005. 30:488–500.
9. Li H, Zeng MS, Zhou KR, et al. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr. 2005. 29:170–175.
10. Brügel M, Rummeny EJ, Dobritz M. Vascular invasion in pancreatic cancer: value of multislice helical CT. Abdom Imaging. 2004. 29:239–245.
11. Tempero MA, Arnoletti JP, Behrman S, et al. NCCN Pancreatic Adenocarcinoma. Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2010. 8:972–1017.
12. Pingpank JF, Hoffman JP, Ross EA, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2001. 5:121–130.
13. Lall CG, Howard TJ, Skandarajah A, et al. New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR Am J Roentgenol. 2007. 189:1044–1050.
14. Bockhorn M, Burdelski C, Bogoevski D, et al. Arterial en bloc resection for pancreatic carcinoma. Br J Surg. 2011. 98:86–92.
15. Bachellier P, Rosso E, Lucescu I, et al. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol. 2011. 103:75–84.
16. Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007. 246:46–51.
Full Text Links
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr